<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Beyond known familial <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) syndromes, the mechanisms underlying the elevated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history remain largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>A recent retrospective study suggests familial clustering of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> with hypomethylation in long interspersed nucleotide element 1 (LINE-1) </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the hypothesis that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history might confer a higher risk of LINE-1 methylation-low <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Using the Nurses' Health Study and the Health Professionals Follow-up Study, we prospectively examined the association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history and the risk of rectal and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (N = 1224) according to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> LINE-1 methylation level by duplication method Cox proportional hazards regression </plain></SENT>
<SENT sid="4" pm="."><plain>We examined microsatellite instability (MSI) status to exclude the influence of <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> statistical tests were two-sided </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The association between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history and non-MSI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk differed statistically significantly by LINE-1 methylation level (P (<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = .02) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history was associated with a statistically significantly higher risk of LINE-1 methylation-low non-MSI <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (multivariable hazard ratio [HR] = 1.68, 95% confidence interval [CI] = 1.19 to 2.38 for 1 vs 0 first-degree relatives with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>; multivariable HR = 3.48, 95% CI = 1.59 to 7.6 for â‰¥2 vs 0 first-degree relatives with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>; P (trend) &lt; .001) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history was not statistically significantly associated with LINE-1 methylation-high non-MSI <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (P (trend) = .35) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This molecular pathological epidemiology study shows that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> family history is associated with a higher risk of LINE-1 methylation-low <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, suggesting previously unrecognized heritable predisposition to epigenetic alterations </plain></SENT>
<SENT sid="10" pm="."><plain>Additional studies are needed to evaluate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> LINE-1 methylation as a molecular biomarker for <z:e sem="disease" ids="C1333600" disease_type="Neoplastic Process" abbrv="">familial cancer</z:e> risk assessment </plain></SENT>
</text></document>